247 related articles for article (PubMed ID: 25453958)
1. Nanobubble-Affibody: Novel ultrasound contrast agents for targeted molecular ultrasound imaging of tumor.
Yang H; Cai W; Xu L; Lv X; Qiao Y; Li P; Wu H; Yang Y; Zhang L; Duan Y
Biomaterials; 2015 Jan; 37():279-88. PubMed ID: 25453958
[TBL] [Abstract][Full Text] [Related]
2. A Novel Bimodal Imaging Agent Targeting HER2 Molecule of Breast Cancer.
Lv W; Shen Y; Yang H; Yang R; Cai W; Zhang J; Yuan L; Duan Y; Zhang L
J Immunol Res; 2018; 2018():6202876. PubMed ID: 29854844
[TBL] [Abstract][Full Text] [Related]
3. Preparation of multifunctional nanobubbles and their application in bimodal imaging and targeted combination therapy of early pancreatic cancer.
Yang H; Zhao P; Zhou Y; Li Q; Cai W; Zhao Z; Shen J; Yao K; Duan Y
Sci Rep; 2021 Mar; 11(1):6254. PubMed ID: 33737559
[TBL] [Abstract][Full Text] [Related]
4. FA-NBs-IR780: Novel multifunctional nanobubbles as molecule-targeted ultrasound contrast agents for accurate diagnosis and photothermal therapy of cancer.
Shen Y; Lv W; Yang H; Cai W; Zhao P; Zhang L; Zhang J; Yuan L; Duan Y
Cancer Lett; 2019 Jul; 455():14-25. PubMed ID: 31018151
[TBL] [Abstract][Full Text] [Related]
5. Novel dual-mode nanobubbles as potential targeted contrast agents for female tumors exploration.
Yang H; Zhou T; Cai W; Yi X; Liu X; Wang Y; Zhang L; Duan Y
Tumour Biol; 2016 Oct; 37(10):14153-14163. PubMed ID: 27539728
[TBL] [Abstract][Full Text] [Related]
6. Methotrexate-loaded PLGA nanobubbles for ultrasound imaging and Synergistic Targeted therapy of residual tumor during HIFU ablation.
Zhang X; Zheng Y; Wang Z; Huang S; Chen Y; Jiang W; Zhang H; Ding M; Li Q; Xiao X; Luo X; Wang Z; Qi H
Biomaterials; 2014 Jun; 35(19):5148-61. PubMed ID: 24680663
[TBL] [Abstract][Full Text] [Related]
7. Neuropeptide Y Y
Li J; Tian Y; Shan D; Gong A; Zeng L; Ren W; Xiang L; Gerhard E; Zhao J; Yang J; Wu A
Biomaterials; 2017 Feb; 116():106-117. PubMed ID: 27914983
[TBL] [Abstract][Full Text] [Related]
8. Annexin V conjugated nanobubbles: A novel ultrasound contrast agent for in vivo assessment of the apoptotic response in cancer therapy.
Zhou T; Cai W; Yang H; Zhang H; Hao M; Yuan L; Liu J; Zhang L; Yang Y; Liu X; Deng J; Zhao P; Yang G; Duan Y
J Control Release; 2018 Apr; 276():113-124. PubMed ID: 29522835
[TBL] [Abstract][Full Text] [Related]
9. The Optimized Fabrication of Nanobubbles as Ultrasound Contrast Agents for Tumor Imaging.
Cai WB; Yang HL; Zhang J; Yin JK; Yang YL; Yuan LJ; Zhang L; Duan YY
Sci Rep; 2015 Sep; 5():13725. PubMed ID: 26333917
[TBL] [Abstract][Full Text] [Related]
10. Folate receptor-targeted ultrasonic PFOB nanoparticles: Synthesis, characterization and application in tumor-targeted imaging.
Li K; Liu Y; Zhang S; Xu Y; Jiang J; Yin F; Hu Y; Han B; Ge S; Zhang L; Wang Y
Int J Mol Med; 2017 Jun; 39(6):1505-1515. PubMed ID: 28487935
[TBL] [Abstract][Full Text] [Related]
11. Production and characterization of a novel long-acting Herceptin-targeted nanobubble contrast agent specific for Her-2-positive breast cancers.
Jiang Q; Hao S; Xiao X; Yao J; Ou B; Zhao Z; Liu F; Pan X; Luo B; Zhi H
Breast Cancer; 2016 May; 23(3):445-55. PubMed ID: 25691133
[TBL] [Abstract][Full Text] [Related]
12. Novel lactoferrin-conjugated amphiphilic poly(aminoethyl ethylene phosphate)/poly(L-lactide) copolymer nanobubbles for tumor-targeting ultrasonic imaging.
Luo B; Liang H; Zhang S; Qin X; Liu X; Liu W; Zeng F; Wu Y; Yang X
Int J Nanomedicine; 2015; 10():5805-17. PubMed ID: 26396514
[TBL] [Abstract][Full Text] [Related]
13. Ultrasound-Based Molecular Imaging of Tumors with PTPmu Biomarker-Targeted Nanobubble Contrast Agents.
Johansen ML; Perera R; Abenojar E; Wang X; Vincent J; Exner AA; Brady-Kalnay SM
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671448
[TBL] [Abstract][Full Text] [Related]
14. Construction of a Tumor-Targeting Nanobubble with Multiple Scattering Interfaces and its Enhancement of Ultrasound Imaging.
Ma Z; Zhang Y; Zhu Y; Cui M; Liu Y; Duan YY; Fan L; Zhang L
Int J Nanomedicine; 2024; 19():4651-4665. PubMed ID: 38799698
[TBL] [Abstract][Full Text] [Related]
15. Optimized Anti-Prostate-Specific Membrane Antigen Single-Chain Variable Fragment-Loaded Nanobubbles as a Novel Targeted Ultrasound Contrast Agent for the Diagnosis of Prostate Cancer.
Ding Y; Cao Q; Qian S; Chen X; Xu Y; Chen J; Shen H
J Ultrasound Med; 2020 Apr; 39(4):761-773. PubMed ID: 31702068
[TBL] [Abstract][Full Text] [Related]
16. Experimental investigation of the penetration of ultrasound nanobubbles in a gastric cancer xenograft.
Fan X; Wang L; Guo Y; Tong H; Li L; Ding J; Huang H
Nanotechnology; 2013 Aug; 24(32):325102. PubMed ID: 23868030
[TBL] [Abstract][Full Text] [Related]
17. The fabrication of novel nanobubble ultrasound contrast agent for potential tumor imaging.
Xing Z; Wang J; Ke H; Zhao B; Yue X; Dai Z; Liu J
Nanotechnology; 2010 Apr; 21(14):145607. PubMed ID: 20220227
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of four affibody-based near-infrared fluorescent probes for optical imaging of epidermal growth factor receptor positive tumors.
Qi S; Miao Z; Liu H; Xu Y; Feng Y; Cheng Z
Bioconjug Chem; 2012 Jun; 23(6):1149-56. PubMed ID: 22621238
[TBL] [Abstract][Full Text] [Related]
19. Targeted Nanobubbles Carrying Indocyanine Green for Ultrasound, Photoacoustic and Fluorescence Imaging of Prostate Cancer.
Wang Y; Lan M; Shen D; Fang K; Zhu L; Liu Y; Hao L; Li P
Int J Nanomedicine; 2020; 15():4289-4309. PubMed ID: 32606678
[TBL] [Abstract][Full Text] [Related]
20. Preparation and Imaging Investigation of Dual-targeted C
Du J; Li XY; Hu H; Xu L; Yang SP; Li FH
Sci Rep; 2018 Mar; 8(1):3887. PubMed ID: 29497045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
